Cognito Therapeutics, Inc.: Clinical Trials

4 trials sponsored by Cognito Therapeutics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 enrolling by invitation, 1 unknown. 4 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable4Active not recruiting 1, Completed 1, Enrolling by invitation 1, Unknown 1

Follow Cognito Therapeutics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Sensory Stimulation System (GS120) - Active - Alzheimer Disease, Cognitive Impairment
Not applicableEnrolling by invitationCognito Therapeutics, Inc.4022024-02-292024-05-07
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Spectris™ AD - Active, Spectris™ AD - Sham - Alzheimer Disease, Alzheimer Disease 1
Not applicableCompletedCognito Therapeutics, Inc.6732022-12-132026-09-09
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
GammaSense Stimulation System (non-invasive, non-significant risk) - Alzheimer Disease, Early Onset, Alzheimer Disease
Not applicableUnknownCognito Therapeutics, Inc.202018-05-312021-08-24
Multi-Center Study of Sensory Stimulation to Improve Brain Function
GammaSense Stimulation System (Active Settings), GammaSense Stimulation System (Sham Settings) - Alzheimer Disease, Cognitive Impairment
Not applicableActive not recruitingCognito Therapeutics, Inc.602018-04-242021-08-24

Conditions studied

Alzheimer Disease (4)  ·  Cognitive Dysfunction (4)  ·  Dementia (4)  ·  Lymphoma, Follicular (4)  ·  Alzheimer Disease 10 (1)  ·  Alzheimer Disease 11 (1)  ·  Alzheimer Disease 12 (1)  ·  Alzheimer Disease 13 (1)  ·  Alzheimer Disease 14 (1)  ·  Alzheimer Disease 15 (1)  ·  Alzheimer Disease 16 (1)  ·  Alzheimer Disease 5 (1)  ·  Alzheimer Disease 6 (1)  ·  Alzheimer Disease 7 (1)  ·  Alzheimer Disease 8 (1)

Countries

United States (4)

Top investigators

Evan R Hempel (1)  ·  Ralph Kern (1)  ·  Robbert Zusterzeel, MD, PhD, MPH (1)

Results publications

PMID 34630050, PMID 38515445, PMID 40082316